Bella Bielorai

2.7k citations
66 papers · 1.6k indexed · h-index 22
Topics
Hematopoietic Stem Cell Transplantation (21 papers)Acute Lymphoblastic Leukemia research (13 papers)CAR-T cell therapy research (12 papers)
Journals
SHILAP Revista de lepidopterologíaBloodPLoS ONE

In The Last Decade

Bella Bielorai

60 papers receiving 1.6k citations

Peers

Bella Bielorai
Comparison fields: 5 of 98
  • Oncology 667
  • Hematology 416
  • Molecular Biology 341
  • Immunology 311
  • Genetics 282
Replace Matthias Eyrich with:
Matthias Eyrich Germany
Ami J. Shah United States
Kristin Baird United States
Bénédicte Brichard Belgium
Paul G. Schlegel Germany
Pietro Merli Italy
Carmem Bonfim Brazil
Mikael Sundin Sweden
Ho Joon Im South Korea
Christian Urban Austria
Bella Bielorai relative to Matthias Eyrich Germany Matthias Eyrich's profile →
Citations per field
00.5×1.5×
Matthias Eyrich · 1×
Citations per year

Countries citing papers authored by Bella Bielorai

Since Specialization
Citations

This map shows the geographic impact of Bella Bielorai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bella Bielorai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bella Bielorai more than expected).

Fields of papers citing papers by Bella Bielorai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bella Bielorai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bella Bielorai. The network helps show where Bella Bielorai may publish in the future.

Co-authorship network of co-authors of Bella Bielorai

This figure shows the co-authorship network connecting the top 25 collaborators of Bella Bielorai. A scholar is included among the top collaborators of Bella Bielorai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bella Bielorai. Bella Bielorai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 5
5 18
6 6
7 7
8 15
9 7
10 44
11 8
12 12
13 15
14 39
15 11
16 21
17 24
18 14
19 21
20 4

About Bella Bielorai

Bella Bielorai is a scholar working on Hematology, Oncology and Immunology, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Lymphoblastic Leukemia research (13 papers) and CAR-T cell therapy research (12 papers). The work is most often cited by research in Hematology (416 citations), Oncology (667 citations) and Genetics (190 citations). Bella Bielorai has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Amos Toren, Gideon Rechavi, Arnon Nagler, Elad Jacoby, Avichai Shimoni, Michal J. Besser, Abraham Avigdor, Jacob Schachter, Amilia Meir and Ninette Amariglio. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026